Hims & Hers Health (HIMS) Non Operating Income (2019 - 2026)
Hims & Hers Health (HIMS) posted Non Operating Income of -$23.2 million for Q1 2026, down 353.39% sequentially from $9.2 million in Q4 2025, and down 994.07% YoY from $2.6 million in Q1 2025.
Hims & Hers Health (HIMS) Non Operating Income (2019 - 2026) Analysis & Trends
Hims & Hers Health has reported Non Operating Income for 8 years, with the latest figure at -$23.2 million in Q1 2026.
- Quarterly Non Operating Income fell 994.07% year-over-year to -$23.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.5 million (down 175.86% YoY) and the FY2025 annual result came in at $18.3 million, up 86.69% from the prior year.
- Non Operating Income declined to -$23.2 million in Q1 2026 per HIMS's latest filing, from $9.2 million in the prior quarter.
- Over five years, Non Operating Income peaked at $9.2 million in Q4 2025 and troughed at -$23.2 million in Q1 2026.
- A 5-year average of $927117.6 and a median of $1.6 million in 2023 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2023 and 2026: Non Operating Income surged 349.91% in 2023, then plunged 994.07% in 2026.
- Over 5 years, Non Operating Income stood at $577000.0 in 2022, then jumped by 349.91% to $2.6 million in 2023, then surged by 42.33% to $3.7 million in 2024, then jumped by 148.09% to $9.2 million in 2025, then tumbled by 353.39% to -$23.2 million in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered -$23.2 million, $9.2 million, and $416000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Hims & Hers Health | 7.51 Bn | 6.67 Bn | 480.80 Mn | 4.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.56 Mn |
| Mar 31, 2026 | -23.23 Mn |
| Dec 31, 2025 | 9.17 Mn |
| Sep 30, 2025 | 416,000.00 |
| Jun 30, 2025 | 6.13 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 2.39 Mn |
| Mar 31, 2024 | 2.50 Mn |
| Dec 31, 2023 | 2.60 Mn |
| Sep 30, 2023 | 1.64 Mn |
| Jun 30, 2023 | 2.07 Mn |
| Mar 31, 2023 | 1.58 Mn |
| Dec 31, 2022 | 577,000.00 |
| Sep 30, 2022 | 1.13 Mn |
| Jun 30, 2022 | 523,000.00 |
| Mar 31, 2022 | 761,000.00 |
| Dec 31, 2021 | -9.68 Mn |
| Sep 30, 2021 | 8.55 Mn |